Valuation models
price $88.00 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused129.98 – 268.86179.4751% undervaluedDCF · Perpetuity growth · 10y129.17 – 266.47178.1351% undervaluedDCF · EBITDA exit · 5y177.79 – 198.00187.6253% undervaluedDCF · EBITDA exit · 10y167.30 – 204.39184.9352% undervaluedP/E · peers107.50 – 167.91143.9739% undervaluedP/E · own history107.28 – 378.21208.4158% undervaluedPEG—85.823% overvaluedEV/EBITDA · peers97.72 – 155.39113.5322% undervaluedEV/Revenue · peers57.26 – 210.35136.8836% undervaluedEarnings power value38.59 – 88.3357.7152% overvaluedDividend discount72.71 – 189.93108.8919% undervaluedWall St. consensus target—91.003% belowCost of capital (WACC)—6.48%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
179.47
Clorox closed at $88.00 — undervalued by 51% vs model.
129.98the model's range268.86
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
57.71 – 208.41
Wall St. target
91.00 3% below
Below model, 1y
27 of 30 days
How it is valued
Valued asMature & stable
Revenue declining (~-3% recent)Moderate margins (9% net margin)Strong dividend yieldHighly cyclical earningsHigh leverage (D/E 61.3x)
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.